ClearCam™ Selected for AFWERX Award
On July 9, 2026, ClearCam™, an innovative medical technology company based in Austin, Texas, celebrated a significant milestone by being awarded a contract worth $74,360 from AFWERX. This funding, part of the SBIR Phase I initiative, aims to accelerate the development of ClearScope IQ™, ClearCam™'s advanced surgical visualization platform embedded with artificial intelligence. This contract underscores the potential application of the technology in enhancing surgical readiness and efficacy within the Department of the Air Force.
ClearCam™ specializes in technologies that facilitate minimally invasive surgical procedures, and the introduction of ClearScope IQ™ is set to redefine surgical visualization standards. The device employs a unique combination of AI-driven algorithms and a mechanical lens cleaner, addressing the essential need for clarity during operations. It aims to assist surgeons in maintaining an unobstructed view, which can sometimes be hindered during complex procedures.
The AFWERX award signifies more than just financial assistance for ClearCam™; it's an opportunity to align their mission with the needs of military medicine. The evolution of ClearScope IQ™ represents a broader vision where innovative surgical tools can leverage intelligent systems to foresee visualization lapses and adapt accordingly. According to Dr. Christopher Idelson, Chief Technology Officer and Co-Founder of ClearCam™, this advancement aims to empower surgical teams with cutting-edge technology that not only improves outcomes for patients but may also lead to transformative changes in surgical practices across various sectors.
The cooperation with AFWERX and the Air Force Research Laboratory is designed to expedite the Small Business Innovation Research (SBIR) process. The collaboration intends to minimize bureaucratic challenges, thus enabling smaller enterprises like ClearCam™ to bring their product offerings to market more swiftly. Since the onset of the Open Topic SBIR/STTR program in 2018, the Department of the Air Force has expanded funding opportunities, recognizing the value that small businesses add to innovation.
As ClearCam™ embarks on this journey following the contract notification on June 25, 2026, their objectives are clear. They aim to delve into potential applications of ClearScope IQ™ not just within military healthcare, but also broaden its utility to civilian medical practices, particularly where surgical precision is paramount.
John Uecker, MD, FACS, and co-founder of ClearCam™, expressed personal sentiment toward the award. As a veteran, the intersection of his professional and personal life with technological advancement in military medicine is particularly meaningful to him. "It is a privilege to collaborate with the Air Force to investigate how our technology can benefit those who serve our nation. We are excited about this venture with AFWERX and the role we will play in bolstering both military and civilian healthcare practices," stated Dr. Uecker.
In summary, the selection of ClearCam™ for the AFWERX award signifies a pivotal step in advancing surgical visualization technologies. As ClearScope IQ™ progresses through the development phase, the potential impact on surgical safety, efficiency, and patient outcomes can not only enhance military medical standards but also set a precedent in the medical device industry. ClearCam™ continues to push the boundaries of innovation, driving toward a future where surgical excellence is the norm across all operating rooms, military, and civilian alike.
For more information about ClearCam™ and their innovative products, visit
ClearCam's official website.